Authors:
ILSON DH
AJANI J
BHALLA K
FORASTIERE A
HUANG Y
PATEL P
MARTIN L
DONEGAN J
PAZDUR R
REED C
KELSEN DP
Citation: Dh. Ilson et al., PHASE-II TRIAL OF PACLITAXEL, FLUOROURACIL, AND CISPLATIN IN PATIENTSWITH ADVANCED-CARCINOMA OF THE ESOPHAGUS, Journal of clinical oncology, 16(5), 1998, pp. 1826-1834
Authors:
SALTZ LB
SCHWARTZ GK
ILSON DH
QUAN V
KELSEN DP
Citation: Lb. Saltz et al., A PHASE-II STUDY OF TOPOTECAN ADMINISTERED 5 TIMES DAILY IN PATIENTS WITH ADVANCED GASTRIC-CANCER, American journal of clinical oncology, 20(6), 1997, pp. 621-625
Citation: Ja. Ajani et al., PACLITAXEL IN THE TREATMENT OF PATIENTS WITH UPPER GASTROINTESTINAL CARCINOMAS, Seminars in oncology, 23(5), 1996, pp. 55-58
Authors:
ILSON DH
SIROTT M
SALTZ L
HEELAN R
HUANG Y
KERESZTES R
KELSEN DP
Citation: Dh. Ilson et al., A PHASE-II TRIAL OF INTERFERON-ALPHA 2A, 5-FLUOROURACIL, AND CISPLATIN IN PATIENTS WITH ADVANCED ESOPHAGEAL-CARCINOMA, Cancer, 75(9), 1995, pp. 2197-2202
Authors:
BOSL GJ
ILSON DH
RODRIGUEZ E
MOTZER RJ
REUTER VE
CHAGANTI RSK
Citation: Gj. Bosl et al., CLINICAL RELEVANCE OF THE I(12P) MARKER CHROMOSOME IN GERM-CELL TUMORS, Journal of the National Cancer Institute, 86(5), 1994, pp. 349-355
Authors:
AJANI JA
ILSON DH
DAUGHERTY K
PAZDUR R
LYNCH PM
KELSEN DP
Citation: Ja. Ajani et al., ACTIVITY OF TAXOL IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA AND ADENOCARCINOMA OF THE ESOPHAGUS, Journal of the National Cancer Institute, 86(14), 1994, pp. 1086-1091
Authors:
AJANI JA
DODD LG
DAUGHERTY K
WARKENTIN D
ILSON DH
Citation: Ja. Ajani et al., TAXOL-INDUCED SOFT-TISSUE INJURY SECONDARY TO EXTRAVASATION - CHARACTERIZATION BY HISTOPATHOLOGY AND CLINICAL COURSE, Journal of the National Cancer Institute, 86(1), 1994, pp. 51-53
Citation: Tm. Law et al., PHASE-II TRIAL OF TOPOTECAN IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Investigational new drugs, 12(2), 1994, pp. 143-145
Citation: Dh. Ilson et al., GENETIC-ANALYSIS IN THE DIAGNOSIS OF NEOPLASMS OF UNKNOWN PRIMARY TUMOR SITE, Seminars in oncology, 20(3), 1993, pp. 229-237